Table of Content

1 Study Coverage
1.1 Plasma Derived Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Derived Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Albumin
1.2.3 Immune Globulin
1.2.4 Coagulation Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma Derived Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Bleeding Wound
1.3.3 Immunodeficiency
1.3.4 HBV
1.3.5 Tetanus
1.3.6 Rabies
1.3.7 Hemophilia
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Plasma Derived Medicine Sales Estimates and Forecasts 2018-2029
2.2 Global Plasma Derived Medicine Revenue by Region
2.2.1 Global Plasma Derived Medicine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Plasma Derived Medicine Revenue by Region (2018-2024)
2.2.3 Global Plasma Derived Medicine Revenue by Region (2024-2029)
2.2.4 Global Plasma Derived Medicine Revenue Market Share by Region (2018-2029)
2.3 Global Plasma Derived Medicine Sales Estimates and Forecasts 2018-2029
2.4 Global Plasma Derived Medicine Sales by Region
2.4.1 Global Plasma Derived Medicine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Plasma Derived Medicine Sales by Region (2018-2024)
2.4.3 Global Plasma Derived Medicine Sales by Region (2024-2029)
2.4.4 Global Plasma Derived Medicine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Plasma Derived Medicine Sales by Manufacturers
3.1.1 Global Plasma Derived Medicine Sales by Manufacturers (2018-2024)
3.1.2 Global Plasma Derived Medicine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Derived Medicine in 2022
3.2 Global Plasma Derived Medicine Revenue by Manufacturers
3.2.1 Global Plasma Derived Medicine Revenue by Manufacturers (2018-2024)
3.2.2 Global Plasma Derived Medicine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Plasma Derived Medicine Revenue in 2022
3.3 Global Key Players of Plasma Derived Medicine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Plasma Derived Medicine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Plasma Derived Medicine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Plasma Derived Medicine, Product Offered and Application
3.8 Global Key Manufacturers of Plasma Derived Medicine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma Derived Medicine Sales by Type
4.1.1 Global Plasma Derived Medicine Historical Sales by Type (2018-2024)
4.1.2 Global Plasma Derived Medicine Forecasted Sales by Type (2024-2029)
4.1.3 Global Plasma Derived Medicine Sales Market Share by Type (2018-2029)
4.2 Global Plasma Derived Medicine Revenue by Type
4.2.1 Global Plasma Derived Medicine Historical Revenue by Type (2018-2024)
4.2.2 Global Plasma Derived Medicine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Plasma Derived Medicine Revenue Market Share by Type (2018-2029)
4.3 Global Plasma Derived Medicine Price by Type
4.3.1 Global Plasma Derived Medicine Price by Type (2018-2024)
4.3.2 Global Plasma Derived Medicine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Plasma Derived Medicine Sales by Application
5.1.1 Global Plasma Derived Medicine Historical Sales by Application (2018-2024)
5.1.2 Global Plasma Derived Medicine Forecasted Sales by Application (2024-2029)
5.1.3 Global Plasma Derived Medicine Sales Market Share by Application (2018-2029)
5.2 Global Plasma Derived Medicine Revenue by Application
5.2.1 Global Plasma Derived Medicine Historical Revenue by Application (2018-2024)
5.2.2 Global Plasma Derived Medicine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Plasma Derived Medicine Revenue Market Share by Application (2018-2029)
5.3 Global Plasma Derived Medicine Price by Application
5.3.1 Global Plasma Derived Medicine Price by Application (2018-2024)
5.3.2 Global Plasma Derived Medicine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Plasma Derived Medicine Market Size by Type
6.1.1 US & Canada Plasma Derived Medicine Sales by Type (2018-2029)
6.1.2 US & Canada Plasma Derived Medicine Revenue by Type (2018-2029)
6.2 US & Canada Plasma Derived Medicine Market Size by Application
6.2.1 US & Canada Plasma Derived Medicine Sales by Application (2018-2029)
6.2.2 US & Canada Plasma Derived Medicine Revenue by Application (2018-2029)
6.3 US & Canada Plasma Derived Medicine Market Size by Country
6.3.1 US & Canada Plasma Derived Medicine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Plasma Derived Medicine Sales by Country (2018-2029)
6.3.3 US & Canada Plasma Derived Medicine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Plasma Derived Medicine Market Size by Type
7.1.1 Europe Plasma Derived Medicine Sales by Type (2018-2029)
7.1.2 Europe Plasma Derived Medicine Revenue by Type (2018-2029)
7.2 Europe Plasma Derived Medicine Market Size by Application
7.2.1 Europe Plasma Derived Medicine Sales by Application (2018-2029)
7.2.2 Europe Plasma Derived Medicine Revenue by Application (2018-2029)
7.3 Europe Plasma Derived Medicine Market Size by Country
7.3.1 Europe Plasma Derived Medicine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Plasma Derived Medicine Sales by Country (2018-2029)
7.3.3 Europe Plasma Derived Medicine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Plasma Derived Medicine Market Size
8.1.1 China Plasma Derived Medicine Sales (2018-2029)
8.1.2 China Plasma Derived Medicine Revenue (2018-2029)
8.2 China Plasma Derived Medicine Market Size by Application
8.2.1 China Plasma Derived Medicine Sales by Application (2018-2029)
8.2.2 China Plasma Derived Medicine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Plasma Derived Medicine Market Size by Type
9.1.1 Asia Plasma Derived Medicine Sales by Type (2018-2029)
9.1.2 Asia Plasma Derived Medicine Revenue by Type (2018-2029)
9.2 Asia Plasma Derived Medicine Market Size by Application
9.2.1 Asia Plasma Derived Medicine Sales by Application (2018-2029)
9.2.2 Asia Plasma Derived Medicine Revenue by Application (2018-2029)
9.3 Asia Plasma Derived Medicine Sales by Region
9.3.1 Asia Plasma Derived Medicine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Plasma Derived Medicine Revenue by Region (2018-2029)
9.3.3 Asia Plasma Derived Medicine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Plasma Derived Medicine Market Size by Type
10.1.1 Middle East, Africa and Latin America Plasma Derived Medicine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Plasma Derived Medicine Market Size by Application
10.2.1 Middle East, Africa and Latin America Plasma Derived Medicine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Plasma Derived Medicine Sales by Country
10.3.1 Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Plasma Derived Medicine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Takeda Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Grifols Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Octapharma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Overview
11.5.3 Kedrion Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Kedrion Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kedrion Recent Developments
11.6 LFB Group
11.6.1 LFB Group Company Information
11.6.2 LFB Group Overview
11.6.3 LFB Group Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 LFB Group Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 LFB Group Recent Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Overview
11.7.3 Biotest Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Biotest Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biotest Recent Developments
11.8 BPL
11.8.1 BPL Company Information
11.8.2 BPL Overview
11.8.3 BPL Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 BPL Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BPL Recent Developments
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Information
11.9.2 Shanghai RAAS Overview
11.9.3 Shanghai RAAS Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Shanghai RAAS Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai RAAS Recent Developments
11.10 China Biologic Products
11.10.1 China Biologic Products Company Information
11.10.2 China Biologic Products Overview
11.10.3 China Biologic Products Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 China Biologic Products Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 China Biologic Products Recent Developments
11.11 Hualan Biological Engineering Inc.
11.11.1 Hualan Biological Engineering Inc. Company Information
11.11.2 Hualan Biological Engineering Inc. Overview
11.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Biological Engineering Inc. Recent Developments
11.12 Beijing Tiantan Biological Products Corp
11.12.1 Beijing Tiantan Biological Products Corp Company Information
11.12.2 Beijing Tiantan Biological Products Corp Overview
11.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Beijing Tiantan Biological Products Corp Recent Developments
11.13 Pacific Shuanglin
11.13.1 Pacific Shuanglin Company Information
11.13.2 Pacific Shuanglin Overview
11.13.3 Pacific Shuanglin Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Pacific Shuanglin Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pacific Shuanglin Recent Developments
11.14 Boya Bio-Pharmaceutical
11.14.1 Boya Bio-Pharmaceutical Company Information
11.14.2 Boya Bio-Pharmaceutical Overview
11.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Boya Bio-Pharmaceutical Recent Developments
11.15 Paisi Feike Biology Pharmacy Co., Ltd.
11.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
11.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Overview
11.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
11.16 Xinjiang Deyuan Bioengineering
11.16.1 Xinjiang Deyuan Bioengineering Company Information
11.16.2 Xinjiang Deyuan Bioengineering Overview
11.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Xinjiang Deyuan Bioengineering Recent Developments
11.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
11.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
11.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Overview
11.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
11.18 Shenzhen Weiguang
11.18.1 Shenzhen Weiguang Company Information
11.18.2 Shenzhen Weiguang Overview
11.18.3 Shenzhen Weiguang Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Shenzhen Weiguang Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Shenzhen Weiguang Recent Developments
11.19 Shanxi Kangbao
11.19.1 Shanxi Kangbao Company Information
11.19.2 Shanxi Kangbao Overview
11.19.3 Shanxi Kangbao Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Shanxi Kangbao Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Shanxi Kangbao Recent Developments
11.20 Nanyue Biopharming Corporation Ltd
11.20.1 Nanyue Biopharming Corporation Ltd Company Information
11.20.2 Nanyue Biopharming Corporation Ltd Overview
11.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plasma Derived Medicine Industry Chain Analysis
12.2 Plasma Derived Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma Derived Medicine Production Mode & Process
12.4 Plasma Derived Medicine Sales and Marketing
12.4.1 Plasma Derived Medicine Sales Channels
12.4.2 Plasma Derived Medicine Distributors
12.5 Plasma Derived Medicine Customers
13 Market Dynamics
13.1 Plasma Derived Medicine Industry Trends
13.2 Plasma Derived Medicine Market Drivers
13.3 Plasma Derived Medicine Market Challenges
13.4 Plasma Derived Medicine Market Restraints
14 Key Findings in The Global Plasma Derived Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Plasma Derived Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Albumin
Table 3. Major Manufacturers of Immune Globulin
Table 4. Major Manufacturers of Coagulation Factor
Table 5. Major Manufacturers of Others
Table 6. Global Plasma Derived Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Plasma Derived Medicine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Plasma Derived Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Plasma Derived Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Plasma Derived Medicine Revenue Market Share by Region (2018-2024)
Table 11. Global Plasma Derived Medicine Revenue Market Share by Region (2024-2029)
Table 12. Global Plasma Derived Medicine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Plasma Derived Medicine Sales by Region (2018-2024) & (K Bottles)
Table 14. Global Plasma Derived Medicine Sales by Region (2024-2029) & (K Bottles)
Table 15. Global Plasma Derived Medicine Sales Market Share by Region (2018-2024)
Table 16. Global Plasma Derived Medicine Sales Market Share by Region (2024-2029)
Table 17. Global Plasma Derived Medicine Sales by Manufacturers (2018-2024) & (K Bottles)
Table 18. Global Plasma Derived Medicine Sales Share by Manufacturers (2018-2024)
Table 19. Global Plasma Derived Medicine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Plasma Derived Medicine Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Plasma Derived Medicine, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Plasma Derived Medicine Price by Manufacturers 2018-2024 (USD/Bottle)
Table 23. Global Plasma Derived Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Plasma Derived Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2022)
Table 25. Global Key Manufacturers of Plasma Derived Medicine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Plasma Derived Medicine, Product Offered and Application
Table 27. Global Key Manufacturers of Plasma Derived Medicine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Plasma Derived Medicine Sales by Type (2018-2024) & (K Bottles)
Table 30. Global Plasma Derived Medicine Sales by Type (2024-2029) & (K Bottles)
Table 31. Global Plasma Derived Medicine Sales Share by Type (2018-2024)
Table 32. Global Plasma Derived Medicine Sales Share by Type (2024-2029)
Table 33. Global Plasma Derived Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Plasma Derived Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Plasma Derived Medicine Revenue Share by Type (2018-2024)
Table 36. Global Plasma Derived Medicine Revenue Share by Type (2024-2029)
Table 37. Plasma Derived Medicine Price by Type (2018-2024) & (USD/Bottle)
Table 38. Global Plasma Derived Medicine Price Forecast by Type (2024-2029) & (USD/Bottle)
Table 39. Global Plasma Derived Medicine Sales by Application (2018-2024) & (K Bottles)
Table 40. Global Plasma Derived Medicine Sales by Application (2024-2029) & (K Bottles)
Table 41. Global Plasma Derived Medicine Sales Share by Application (2018-2024)
Table 42. Global Plasma Derived Medicine Sales Share by Application (2024-2029)
Table 43. Global Plasma Derived Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Plasma Derived Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Plasma Derived Medicine Revenue Share by Application (2018-2024)
Table 46. Global Plasma Derived Medicine Revenue Share by Application (2024-2029)
Table 47. Plasma Derived Medicine Price by Application (2018-2024) & (USD/Bottle)
Table 48. Global Plasma Derived Medicine Price Forecast by Application (2024-2029) & (USD/Bottle)
Table 49. US & Canada Plasma Derived Medicine Sales by Type (2018-2024) & (K Bottles)
Table 50. US & Canada Plasma Derived Medicine Sales by Type (2024-2029) & (K Bottles)
Table 51. US & Canada Plasma Derived Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Plasma Derived Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Plasma Derived Medicine Sales by Application (2018-2024) & (K Bottles)
Table 54. US & Canada Plasma Derived Medicine Sales by Application (2024-2029) & (K Bottles)
Table 55. US & Canada Plasma Derived Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Plasma Derived Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Plasma Derived Medicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Plasma Derived Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Plasma Derived Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Plasma Derived Medicine Sales by Country (2018-2024) & (K Bottles)
Table 61. US & Canada Plasma Derived Medicine Sales by Country (2024-2029) & (K Bottles)
Table 62. Europe Plasma Derived Medicine Sales by Type (2018-2024) & (K Bottles)
Table 63. Europe Plasma Derived Medicine Sales by Type (2024-2029) & (K Bottles)
Table 64. Europe Plasma Derived Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Plasma Derived Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Plasma Derived Medicine Sales by Application (2018-2024) & (K Bottles)
Table 67. Europe Plasma Derived Medicine Sales by Application (2024-2029) & (K Bottles)
Table 68. Europe Plasma Derived Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Plasma Derived Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Plasma Derived Medicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Plasma Derived Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Plasma Derived Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Plasma Derived Medicine Sales by Country (2018-2024) & (K Bottles)
Table 74. Europe Plasma Derived Medicine Sales by Country (2024-2029) & (K Bottles)
Table 75. China Plasma Derived Medicine Sales by Type (2018-2024) & (K Bottles)
Table 76. China Plasma Derived Medicine Sales by Type (2024-2029) & (K Bottles)
Table 77. China Plasma Derived Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Plasma Derived Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Plasma Derived Medicine Sales by Application (2018-2024) & (K Bottles)
Table 80. China Plasma Derived Medicine Sales by Application (2024-2029) & (K Bottles)
Table 81. China Plasma Derived Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Plasma Derived Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Plasma Derived Medicine Sales by Type (2018-2024) & (K Bottles)
Table 84. Asia Plasma Derived Medicine Sales by Type (2024-2029) & (K Bottles)
Table 85. Asia Plasma Derived Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Plasma Derived Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Plasma Derived Medicine Sales by Application (2018-2024) & (K Bottles)
Table 88. Asia Plasma Derived Medicine Sales by Application (2024-2029) & (K Bottles)
Table 89. Asia Plasma Derived Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Plasma Derived Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Plasma Derived Medicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Plasma Derived Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Plasma Derived Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Plasma Derived Medicine Sales by Region (2018-2024) & (K Bottles)
Table 95. Asia Plasma Derived Medicine Sales by Region (2024-2029) & (K Bottles)
Table 96. Middle East, Africa and Latin America Plasma Derived Medicine Sales by Type (2018-2024) & (K Bottles)
Table 97. Middle East, Africa and Latin America Plasma Derived Medicine Sales by Type (2024-2029) & (K Bottles)
Table 98. Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Plasma Derived Medicine Sales by Application (2018-2024) & (K Bottles)
Table 101. Middle East, Africa and Latin America Plasma Derived Medicine Sales by Application (2024-2029) & (K Bottles)
Table 102. Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Plasma Derived Medicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Plasma Derived Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Plasma Derived Medicine Sales by Country (2018-2024) & (K Bottles)
Table 108. Middle East, Africa and Latin America Plasma Derived Medicine Sales by Country (2024-2029) & (K Bottles)
Table 109. Takeda Company Information
Table 110. Takeda Description and Major Businesses
Table 111. Takeda Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 112. Takeda Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Takeda Recent Developments
Table 114. CSL Company Information
Table 115. CSL Description and Major Businesses
Table 116. CSL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 117. CSL Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. CSL Recent Developments
Table 119. Grifols Company Information
Table 120. Grifols Description and Major Businesses
Table 121. Grifols Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 122. Grifols Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Grifols Recent Developments
Table 124. Octapharma Company Information
Table 125. Octapharma Description and Major Businesses
Table 126. Octapharma Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 127. Octapharma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Octapharma Recent Developments
Table 129. Kedrion Company Information
Table 130. Kedrion Description and Major Businesses
Table 131. Kedrion Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 132. Kedrion Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Kedrion Recent Developments
Table 134. LFB Group Company Information
Table 135. LFB Group Description and Major Businesses
Table 136. LFB Group Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 137. LFB Group Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. LFB Group Recent Developments
Table 139. Biotest Company Information
Table 140. Biotest Description and Major Businesses
Table 141. Biotest Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 142. Biotest Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Biotest Recent Developments
Table 144. BPL Company Information
Table 145. BPL Description and Major Businesses
Table 146. BPL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 147. BPL Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. BPL Recent Developments
Table 149. Shanghai RAAS Company Information
Table 150. Shanghai RAAS Description and Major Businesses
Table 151. Shanghai RAAS Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 152. Shanghai RAAS Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Shanghai RAAS Recent Developments
Table 154. China Biologic Products Company Information
Table 155. China Biologic Products Description and Major Businesses
Table 156. China Biologic Products Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 157. China Biologic Products Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. China Biologic Products Recent Developments
Table 159. Hualan Biological Engineering Inc. Company Information
Table 160. Hualan Biological Engineering Inc. Description and Major Businesses
Table 161. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 162. Hualan Biological Engineering Inc. Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Hualan Biological Engineering Inc. Recent Developments
Table 164. Beijing Tiantan Biological Products Corp Company Information
Table 165. Beijing Tiantan Biological Products Corp Description and Major Businesses
Table 166. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 167. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Beijing Tiantan Biological Products Corp Recent Developments
Table 169. Pacific Shuanglin Company Information
Table 170. Pacific Shuanglin Description and Major Businesses
Table 171. Pacific Shuanglin Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 172. Pacific Shuanglin Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Pacific Shuanglin Recent Developments
Table 174. Boya Bio-Pharmaceutical Company Information
Table 175. Boya Bio-Pharmaceutical Description and Major Businesses
Table 176. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 177. Boya Bio-Pharmaceutical Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Boya Bio-Pharmaceutical Recent Developments
Table 179. Paisi Feike Biology Pharmacy Co., Ltd. Company Information
Table 180. Paisi Feike Biology Pharmacy Co., Ltd. Description and Major Businesses
Table 181. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 182. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
Table 184. Xinjiang Deyuan Bioengineering Company Information
Table 185. Xinjiang Deyuan Bioengineering Description and Major Businesses
Table 186. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 187. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Xinjiang Deyuan Bioengineering Recent Developments
Table 189. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
Table 190. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 191. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 192. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
Table 194. Shenzhen Weiguang Company Information
Table 195. Shenzhen Weiguang Description and Major Businesses
Table 196. Shenzhen Weiguang Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 197. Shenzhen Weiguang Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Shenzhen Weiguang Recent Developments
Table 199. Shanxi Kangbao Company Information
Table 200. Shanxi Kangbao Description and Major Businesses
Table 201. Shanxi Kangbao Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 202. Shanxi Kangbao Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Shanxi Kangbao Recent Developments
Table 204. Nanyue Biopharming Corporation Ltd Company Information
Table 205. Nanyue Biopharming Corporation Ltd Description and Major Businesses
Table 206. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2024)
Table 207. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 208. Nanyue Biopharming Corporation Ltd Recent Developments
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. Plasma Derived Medicine Distributors List
Table 212. Plasma Derived Medicine Customers List
Table 213. Plasma Derived Medicine Market Trends
Table 214. Plasma Derived Medicine Market Drivers
Table 215. Plasma Derived Medicine Market Challenges
Table 216. Plasma Derived Medicine Market Restraints
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Derived Medicine Product Picture
Figure 2. Global Plasma Derived Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Plasma Derived Medicine Market Share by Type in 2022 & 2029
Figure 4. Albumin Product Picture
Figure 5. Immune Globulin Product Picture
Figure 6. Coagulation Factor Product Picture
Figure 7. Others Product Picture
Figure 8. Global Plasma Derived Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Plasma Derived Medicine Market Share by Application in 2022 & 2029
Figure 10. Bleeding Wound
Figure 11. Immunodeficiency
Figure 12. HBV
Figure 13. Tetanus
Figure 14. Rabies
Figure 15. Hemophilia
Figure 16. Others
Figure 17. Plasma Derived Medicine Report Years Considered
Figure 18. Global Plasma Derived Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Plasma Derived Medicine Revenue 2018-2029 (US$ Million)
Figure 20. Global Plasma Derived Medicine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 21. Global Plasma Derived Medicine Revenue Market Share by Region (2018-2029)
Figure 22. Global Plasma Derived Medicine Sales 2018-2029 ((K Bottles)
Figure 23. Global Plasma Derived Medicine Sales Market Share by Region (2018-2029)
Figure 24. US & Canada Plasma Derived Medicine Sales YoY (2018-2029) & (K Bottles)
Figure 25. US & Canada Plasma Derived Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Europe Plasma Derived Medicine Sales YoY (2018-2029) & (K Bottles)
Figure 27. Europe Plasma Derived Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. China Plasma Derived Medicine Sales YoY (2018-2029) & (K Bottles)
Figure 29. China Plasma Derived Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Asia (excluding China) Plasma Derived Medicine Sales YoY (2018-2029) & (K Bottles)
Figure 31. Asia (excluding China) Plasma Derived Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Plasma Derived Medicine Sales YoY (2018-2029) & (K Bottles)
Figure 33. Middle East, Africa and Latin America Plasma Derived Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 34. The Plasma Derived Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 35. The Top 5 and 10 Largest Manufacturers of Plasma Derived Medicine in the World: Market Share by Plasma Derived Medicine Revenue in 2022
Figure 36. Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global Plasma Derived Medicine Sales Market Share by Type (2018-2029)
Figure 38. Global Plasma Derived Medicine Revenue Market Share by Type (2018-2029)
Figure 39. Global Plasma Derived Medicine Sales Market Share by Application (2018-2029)
Figure 40. Global Plasma Derived Medicine Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Plasma Derived Medicine Sales Market Share by Type (2018-2029)
Figure 42. US & Canada Plasma Derived Medicine Revenue Market Share by Type (2018-2029)
Figure 43. US & Canada Plasma Derived Medicine Sales Market Share by Application (2018-2029)
Figure 44. US & Canada Plasma Derived Medicine Revenue Market Share by Application (2018-2029)
Figure 45. US & Canada Plasma Derived Medicine Revenue Share by Country (2018-2029)
Figure 46. US & Canada Plasma Derived Medicine Sales Share by Country (2018-2029)
Figure 47. U.S. Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 48. Canada Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 49. Mexico Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 50. Europe Plasma Derived Medicine Sales Market Share by Type (2018-2029)
Figure 51. Europe Plasma Derived Medicine Revenue Market Share by Type (2018-2029)
Figure 52. Europe Plasma Derived Medicine Sales Market Share by Application (2018-2029)
Figure 53. Europe Plasma Derived Medicine Revenue Market Share by Application (2018-2029)
Figure 54. Europe Plasma Derived Medicine Revenue Share by Country (2018-2029)
Figure 55. Europe Plasma Derived Medicine Sales Share by Country (2018-2029)
Figure 56. Germany Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 57. France Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 58. UK Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 59. Italy Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 60. Russia Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 61. China Plasma Derived Medicine Sales Market Share by Type (2018-2029)
Figure 62. China Plasma Derived Medicine Revenue Market Share by Type (2018-2029)
Figure 63. China Plasma Derived Medicine Sales Market Share by Application (2018-2029)
Figure 64. China Plasma Derived Medicine Revenue Market Share by Application (2018-2029)
Figure 65. Asia Plasma Derived Medicine Sales Market Share by Type (2018-2029)
Figure 66. Asia Plasma Derived Medicine Revenue Market Share by Type (2018-2029)
Figure 67. Asia Plasma Derived Medicine Sales Market Share by Application (2018-2029)
Figure 68. Asia Plasma Derived Medicine Revenue Market Share by Application (2018-2029)
Figure 69. Asia Plasma Derived Medicine Revenue Share by Region (2018-2029)
Figure 70. Asia Plasma Derived Medicine Sales Share by Region (2018-2029)
Figure 71. Japan Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 72. South Korea Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 73. China Taiwan Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 74. Southeast Asia Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 75. India Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Plasma Derived Medicine Sales Market Share by Type (2018-2029)
Figure 77. Middle East, Africa and Latin America Plasma Derived Medicine Revenue Market Share by Type (2018-2029)
Figure 78. Middle East, Africa and Latin America Plasma Derived Medicine Sales Market Share by Application (2018-2029)
Figure 79. Middle East, Africa and Latin America Plasma Derived Medicine Revenue Market Share by Application (2018-2029)
Figure 80. Middle East, Africa and Latin America Plasma Derived Medicine Revenue Share by Country (2018-2029)
Figure 81. Middle East, Africa and Latin America Plasma Derived Medicine Sales Share by Country (2018-2029)
Figure 82. Brazil Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 83. Mexico Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 84. Turkey Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 85. Israel Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 86. GCC Countries Plasma Derived Medicine Revenue (2018-2029) & (US$ Million)
Figure 87. Plasma Derived Medicine Value Chain
Figure 88. Plasma Derived Medicine Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed